INS and Hyperglycemia: At this moment, the US Food and Drug Administration (FDA) has approved a device with a CGM gadget and an insulin pump, capable of stopping the insulin infusion in case of hypoglycemia (Medtronic 530G) and, recently, the FDA has also approved the Medtronic 670G, which is also able to minimize hyperglycemia thanks to its connection to the CGM gadget.